title: Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease.
abstract: Alterations in neurotransmitter receptors are a pathological hallmark of the neurodegeneration seen in Huntington's disease (HD). However, the significance of these alterations has been uncertain, possibly reflecting simply the loss of brain cells. It is not known for certain whether the alteration of neurotransmitter receptors occurs before the onset of symptoms in human HD. Recently we developed transgenic mice that contain a portion of a human HD gene and develop a progressive abnormal neurological phenotype. Neurotransmitter receptors that are altered in HD (receptors for glutamate, dopamine, acetylcholine and adenosine) are decreased in the brain transgenic mice, in some cases before the onset of behavioural or motor symptoms. In transgenic mice, neurotransmitter receptor alterations occur before neuronal death. Further, receptor alterations are selective in that certain receptors, namely N-methyl-D-aspartate and gamma-aminobutyric acid receptors, are unaltered. Finally, receptor decreases are preceded by selective decreases in the corresponding mRNA species, suggesting the altered transcription of specific genes. These results suggest that (i) receptor decreases precede, and therefore might contribute to, the development of clinical symptoms, and (ii) altered transcription of specific genes might be a key pathological mechanism in HD.
authors.affiliation: Department of Neurology, Massachusetts General Hospital, Boston 02114, USA. cha@helix.mgh.harvard.edu
authors.forename: J H
authors.initials: JH
authors.lastname: Cha
authors.forename: A S
authors.initials: AS
authors.lastname: Frey
authors.forename: S A
authors.initials: SA
authors.lastname: Alsdorf
authors.forename: J A
authors.initials: JA
authors.lastname: Kerner
authors.forename: C M
authors.initials: CM
authors.lastname: Kosinski
authors.forename: L
authors.initials: L
authors.lastname: Mangiarini
authors.forename: J B
authors.initials: JB
authors.lastname: Penney
authors.forename: S W
authors.initials: SW
authors.lastname: Davies
authors.forename: G P
authors.initials: GP
authors.lastname: Bates
authors.forename: A B
authors.initials: AB
authors.lastname: Young
mesh_terms: D000818:Animals; D001921:Brain / Q000473:pathology*; D002467:Cell Nucleus / Q000473:pathology / Q000648:ultrastructure; D006801:Humans; D000071058:Huntingtin Protein; D006816:Huntington Disease / Q000235:genetics / Q000473:pathology*; D051379:Mice; D008822:Mice, Transgenic; D009410:Nerve Degeneration / Q000235:genetics / Q000473:pathology*; D009419:Nerve Tissue Proteins / Q000235:genetics; D009474:Neurons / Q000473:pathology* / Q000648:ultrastructure; D009687:Nuclear Proteins / Q000235:genetics; D010455:Peptides / Q000235:genetics; D020449:Repetitive Sequences, Amino Acid
chemical_list: C086055:HTT protein, human; C506812:Htt protein, mouse; D000071058:Huntingtin Protein; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D010455:Peptides; C097188:polyglutamine